STOCK TITAN

Tivic Health Systems, Inc. to Report Third Quarter 2024 Financial Results on November 14

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Tivic Health Systems (Nasdaq: TIVC), a bioelectronic medicine health tech company, has announced it will release its third quarter 2024 financial results on Thursday, November 14 after market close. The company will host a pre-recorded conference call and webcast at 1:30 p.m. PST / 4:30 p.m. EST. Shareholders and interested parties can participate via phone or webcast, with questions to be submitted to ir@tivichealth.com by November 11.

Tivic Health Systems (Nasdaq: TIVC), un'azienda di tecnologia sanitaria che si occupa di medicina bioelettronica, ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 giovedì 14 novembre dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica pre-registrata e un webcast alle 13:30 PST / 16:30 EST. Gli azionisti e le parti interessate possono partecipare via telefono o tramite webcast, con domande da inviare a ir@tivichealth.com entro l'11 novembre.

Tivic Health Systems (Nasdaq: TIVC), una empresa de tecnología sanitaria en medicina bioelectrónica, ha anunciado que dará a conocer sus resultados financieros del tercer trimestre de 2024 el jueves 14 de noviembre después del cierre del mercado. La empresa realizará una conferencia telefónica y webcast pregrabados a la 1:30 p.m. PST / 4:30 p.m. EST. Los accionistas y partes interesadas pueden participar por teléfono o webcast, con preguntas que deben enviarse a ir@tivichealth.com antes del 11 de noviembre.

Tivic Health Systems (Nasdaq: TIVC), 바이오 전자 의학 기술 회사,는 2024년 3분기 재무 결과를 11월 14일 목요일 시장 마감 후 발표할 것이라고 밝혔습니다. 회사는 태평양 표준시 오후 1시 30분/동부 표준시 오후 4시 30분에 사전 녹화된 전화 회의와 웹 캐스트를 진행할 예정입니다. 주주와 관심 있는 기업들은 전화 또는 웹 캐스트를 통해 참여할 수 있으며, 질문은 11월 11일까지 ir@tivichealth.com으로 제출해야 합니다.

Tivic Health Systems (Nasdaq: TIVC), une entreprise de technologie de santé en médecine bioélectronique, a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 le jeudi 14 novembre après la clôture du marché. L'entreprise organisera une conférence téléphonique et un webinaire préenregistrés à 13h30 PST / 16h30 EST. Les actionnaires et les parties intéressées peuvent participer par téléphone ou via le webinaire, les questions devant être soumises à ir@tivichealth.com avant le 11 novembre.

Tivic Health Systems (Nasdaq: TIVC), ein Unternehmen der Gesundheits-Technologie im Bereich der bioelektronischen Medizin, hat bekannt gegeben, dass es am Donnerstag, den 14. November, nach Börsenschluss seine Finanzergebnisse für das dritte Quartal 2024 veröffentlichen wird. Das Unternehmen wird um 13:30 Uhr PST / 16:30 Uhr EST eine aufgezeichnete Telefonkonferenz und einen Webcast veranstalten. Aktionäre und Interessierte können per Telefon oder Webcast teilnehmen, wobei Fragen bis zum 11. November an ir@tivichealth.com gesendet werden müssen.

Positive
  • None.
Negative
  • None.

– Conference Call and Webcast to Follow at 1:30 p.m. PST/4:30 p.m. EST -

FREMONT, Calif.--(BUSINESS WIRE)-- Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced it will report financial results on Thursday, November 14 after market close. The release will be followed by a pre-recorded conference call and webcast at 1:30 p.m. PST / 4:30 p.m. EST. Shareholders, interested parties, and prospective investors are invited to join via dial in or webcast. The company invites questions to be submitted to ir@tivichealth.com by November 11.

Conference Call Details:
Toll Free: 877-545-0523
International: 973-528-0016
Access Code: 507355

Webcast Link
https://www.webcaster4.com/Webcast/Page/2865/51524

About Tivic Health

Tivic Health is a commercial health tech company advancing the field of bioelectronic medicine. Tivic Health’s technology platforms leverage stimulation of the trigeminal, sympathetic, and vagus nerve structures. Tivic Health’s non-invasive and targeted approach to the treatment of inflammatory chronic health conditions gives consumers and providers drug-free therapeutic solutions with high safety profiles, low risk, and broad applications. Tivic Health’s first commercial product ClearUP is an FDA approved, award-winning, handheld bioelectronic sinus device. ClearUP is clinically proven, doctor-recommended, and is available through online retailers and commercial distributors. For more information visit http://tivichealth.com @TivicHealth

Media Contact:

Morgan Luke

Morgan.Luke@tivichealth.com

Investor Contact:

Hanover International, Inc.

ir@tivichealth.com

Source: Tivic Health Systems, Inc.

FAQ

When will Tivic Health (TIVC) report Q3 2024 earnings?

Tivic Health will report its third quarter 2024 financial results on Thursday, November 14, after market close.

How can investors join Tivic Health's (TIVC) Q3 2024 earnings call?

Investors can join via phone (toll-free: 877-545-0523 or international: 973-528-0016, access code: 507355) or through the webcast link provided.

What is the deadline to submit questions for Tivic Health's (TIVC) Q3 2024 earnings call?

Questions must be submitted to ir@tivichealth.com by November 11.

Tivic Health Systems, Inc.

NASDAQ:TIVC

TIVC Rankings

TIVC Latest News

TIVC Stock Data

1.83M
8.25M
0.25%
3.64%
1.8%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
FREMONT